0001237899-11-000050.txt : 20110902 0001237899-11-000050.hdr.sgml : 20110902 20110902164525 ACCESSION NUMBER: 0001237899-11-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110831 FILED AS OF DATE: 20110902 DATE AS OF CHANGE: 20110902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAGELOS P ROY CENTRAL INDEX KEY: 0001013064 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 111074036 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2011-08-31 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001013064 VAGELOS P ROY 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 Chairman of the Board Common Stock 2011-08-31 4 M 0 312500 28.01 A 452587 D Common Stock 2011-08-31 4 F 0 143587 60.96 D 309000 D Common Stock 2011-08-31 4 F 0 76458 60.96 D 232542 D Common Stock 2011-09-01 4 S 0 3500 60 D 229042 D Common Stock 2011-09-02 4 S 0 35968 60.35 D 193074 D Common Stock 2011-09-02 4 S 0 29529 61.42 D 163545 D Common Stock 2011-09-02 4 S 0 23458 62.04 D 140087 D Common Stock 2271 I By 401(k) Plan Common Stock 175056 I by CLAT Common Stock 94222 I by GRAT Common Stock 160000 I by Spouse as Trustee Common Stock 1203 I by trust for grandch Non-Qualified Stock Option (right to buy) 28.01 2011-08-31 4 M 0 312500 D 2002-12-18 2011-12-18 Common Stock 312500 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 3,500 shares of Company stock on September 1, 2011 at prices ranging from $60.00 to $60.03. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 1, 2011 at each separate price. Represents volume-weighted average price of sales of 35,698 shares of Company stock on September 2, 2011 at prices ranging from $60.00 to $60.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price. Represents volume-weighted average price of sales of 29,529 shares of Company stock on September 2, 2011 at prices ranging from $61.06 to $61.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price. Represents volume-weighted average price of sales of 23,458 shares of Company stock on September 2, 2011 at prices ranging from $62.01 to $62.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 2, 2011 at each separate price. By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee. By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**P. Roy Vagelos 2011-09-02